Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Salmeterol xinafoate

Base Information Edit
  • Chemical Name:Salmeterol xinafoate
  • CAS No.:94749-08-3
  • Molecular Formula:C11H8O3*C25H37NO4
  • Molecular Weight:603.756
  • Hs Code.:2922504500
  • European Community (EC) Number:638-765-3
  • UNII:6EW8Q962A5
  • DSSTox Substance ID:DTXSID1045798
  • Wikidata:Q27264747
  • NCI Thesaurus Code:C61935
  • RXCUI:72616
  • Pharos Ligand ID:X3GGJ7GNYWXG
  • ChEMBL ID:CHEMBL1082607
  • Mol file:94749-08-3.mol
Salmeterol xinafoate

Synonyms:salmeterol;salmeterol xinafoate;Serevent;Xinafoate, Salmeterol

Suppliers and Price of Salmeterol xinafoate
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • Salmeterol xinafoate
  • 10mg
  • $ 389.00
  • TRC
  • Salmeterol Xinafoate
  • 10mg
  • $ 80.00
  • Tocris
  • Salmeterol Xinafoate ≥99%(HPLC)
  • 50
  • $ 616.00
  • Tocris
  • Salmeterol Xinafoate ≥99%(HPLC)
  • 10
  • $ 151.00
  • TCI Chemical
  • Salmeterol Xinafoate >98.0%(HPLC)(T)
  • 250mg
  • $ 53.00
  • TCI Chemical
  • Salmeterol Xinafoate >98.0%(HPLC)(T)
  • 1g
  • $ 145.00
  • Sigma-Aldrich
  • Salmeterol xinafoate European Pharmacopoeia (EP) Reference Standard
  • $ 190.00
  • Sigma-Aldrich
  • Salmeterol xinafoate for system suitability European Pharmacopoeia (EP) Reference Standard
  • y0000423
  • $ 190.00
  • Sigma-Aldrich
  • Salmeterol xinafoate European Pharmacopoeia (EP) Reference Standard
  • y0000422
  • $ 190.00
  • Sigma-Aldrich
  • Salmeterol xinafoate ≥98% (HPLC), solid
  • 10mg
  • $ 188.00
Total 152 raw suppliers
Chemical Property of Salmeterol xinafoate Edit
Chemical Property:
  • Appearance/Colour:white to off-white solid 
  • Vapor Pressure:2.16E-15mmHg at 25°C 
  • Melting Point:137-138 °C 
  • Refractive Index:1.565 
  • Boiling Point:603 °C at 760 mmHg 
  • Flash Point:318.5 °C 
  • PSA:139.48000 
  • Density:1.112g/cm3 
  • LogP:6.74190 
  • Storage Temp.:-20°C Freezer 
  • Solubility.:H2O: slightly soluble 
  • Hydrogen Bond Donor Count:6
  • Hydrogen Bond Acceptor Count:8
  • Rotatable Bond Count:17
  • Exact Mass:603.31960277
  • Heavy Atom Count:44
  • Complexity:629
Purity/Quality:

99.9% *data from raw suppliers

Salmeterol xinafoate *data from reagent suppliers

Safty Information:
  • Pictogram(s): IrritantXi 
  • Hazard Codes:Xi 
  • Statements: 36/37/38 
  • Safety Statements: 22-24/25-36-26 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O
  • Recent ClinicalTrials:Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma
  • Recent EU Clinical Trials:A comparative study to assess a fixed-dose combination of Budesonide-Salmeterol versus Serevent? Diskus? 50 μg + Pulmicort? Turbuhaler? 100 μg co-administrated in asthmatic children: single dose, cross-over, randomized, 3-treatment
  • Recent NIPH Clinical Trials:Compared study of KRP-108
  • Description Salmeterol hydroxynaphthoate is a new long-acting β2-selective adrenoceptor agonist introduced as a bronchodilator for the treatment of reversible airway obstruction in asthma and chronic bronchitis. It has bronchodilatory activity as intense and four times longerlasting than equivalent doses of salbutamol. Salmeterol hydroxynaphthoate is reported to be the first bronchodilator with significant anti-inflammatory activity and hence could complement prophylactic corticosteroid therapy. Salmeterol is a long-acting β2-adrenergic receptor agonist (β2-AR; EC50s = 0.79, 63.1, and 9.4 nM for β2-, β1-, and β3-ARs, respectively). It inhibits electrically-stimulated contraction of isolated guinea pig trachea strips (EC50 = 2.51 nM) and histamine-induced bronchoconstriction in guinea pigs via aerosol administration of doses ranging from 0.12 to 12 mM. Salmeterol binds to an exosite domain of β2-adrenergic receptors, producing a slow onset of action and prolonged activation. Formulations containing salmeterol have been used in the treatment of asthma, including exercise-induced asthma, and chronic obstructive pulmonary disease.
  • Uses A ?-Adrenergic agonist. Structural analog of albuterol A β2-Adrenergic agonist. Structural analog of Albuterol (A514500). Smooth wheezing anti-inflammatory Bronchodilator; Beta2-adrenoceptor agonist
Technology Process of Salmeterol xinafoate

There total 34 articles about Salmeterol xinafoate which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
In acetone; at 30 ℃; for 0.666667h; Temperature; Solvent;
Guidance literature:
Multi-step reaction with 5 steps
1.1: potassium carbonate / potassium iodide / N,N-dimethyl-formamide / 0 - 20 °C / Inert atmosphere
1.2: pH 1 - 1.5
2.1: potassium carbonate / N,N-dimethyl-formamide / 2 h / 10 °C
3.1: lithium aluminium tetrahydride / tetrahydrofuran / 1.5 h / 0 - 10 °C
3.2: 0 °C
4.1: hydrogen / palladium 10% on activated carbon / methanol / 2 h / 40 °C / 3677.86 - 4413.43 Torr
5.1: acetone / 1.5 h / 25 - 45 °C
With lithium aluminium tetrahydride; hydrogen; potassium carbonate; palladium 10% on activated carbon; potassium iodide; In tetrahydrofuran; methanol; N,N-dimethyl-formamide; acetone;
Guidance literature:
Multi-step reaction with 4 steps
1.1: potassium carbonate / N,N-dimethyl-formamide / 2 h / 10 °C
2.1: lithium aluminium tetrahydride / tetrahydrofuran / 1.5 h / 0 - 10 °C
2.2: 0 °C
3.1: hydrogen / palladium 10% on activated carbon / methanol / 2 h / 40 °C / 3677.86 - 4413.43 Torr
4.1: acetone / 1.5 h / 25 - 45 °C
With lithium aluminium tetrahydride; hydrogen; potassium carbonate; palladium 10% on activated carbon; In tetrahydrofuran; methanol; N,N-dimethyl-formamide; acetone;
Refernces Edit
Post RFQ for Price